BiotechTube
Home/Renalytix/Joel R. Jung
JR

Joel R. Jung

Interim Chief Financial Officer

Renalytix

Therapeutic Areas

Kidney DiseaseDiabetic Kidney DiseaseCardiorenal Syndrome

Renalytix Pipeline

DrugIndicationPhase
KidneyIntelX.dkdProgressive decline in kidney function in adults with Type 2 Diabetes and CKD Stages 1-3bCommercial
KidneyIntelX in Heart FailureRisk of worsening kidney function in patients with heart failureDevelopment
KidneyIntelX for CKD EtiologyDisease sub-typing and causation in broad CKD populationResearch

Leadership Team at Renalytix

JM
James McCullough
Chief Executive Officer, Co-Founder
FF
Fergus Fleming
Chief Technology Officer, Co-Founder
HD
Howard Doran
President
MJ
Michael J. Donovan
Chief Medical Officer
View full Renalytix profile